What is EBODAC
In response to the ongoing Ebola virus crisis the Ebola Vaccine Deployment, Acceptance and Compliance (EBODAC) consortium has been developing strategies and tools to promote the acceptance and uptake of new Ebola vaccines, to help the right persons receive the right vaccine at the right time. According to the WHO, good outbreak control relies on a package of interventions namely, community engagement, contact tracing and social mobilisation.
EBODAC uses community engagement, enabling technologies such as iris scanning and phone messaging as well as clear communication methods to build trust and address misconceptions surrounding the vaccine in the community.
EBODAC worked to build local knowledge and capacity and strengthen health systems by working with Ministries of Health and Community Health Workers by providing training and preparedness activities for the potential future deployment of a licensed vaccine. Funded by the European Union, our partners in the consortium are Janssen Pharmaceuticals, London School of Hygiene and Tropical Medicine and Grameen Foundation.